Mirantus Health Raises €5.5 Million Seed Round to Expand Digital Eye‑Screening Platform Across DACH Region
Berlin‑based health technology startup Mirantus Health has secured €5.5 million in a seed funding round to accelerate the expansion of its digital eye‑screening platform mira across the DACH region (Germany, Austria and Switzerland). The investment will help the company scale its innovative solution designed to improve access to specialist ophthalmological care amid rising demand and workforce shortages in eye health services.
The seed round was backed by a group of prominent investors, including Revent, early‑stage technology investors with a strong focus on healthtech and digital innovation, Redstone, a Berlin‑based venture capital firm investing across tech and healthcare sectors, Entrepreneur First, the global talent investor that co‑founds startups with founders before they raise capital, Noaber, a Dutch impact investor focused on health and sustainability, Arve Capital, a European venture investor targeting technology‑driven companies, and individual participation from telemedicine veterans including Kai Eberhardt of Oviva and Katharina Jünger of TeleClinic.
Founded in 2022 by Dominik Pederzani, Mirantus Health has developed mira to address critical bottlenecks in ophthalmological care, where long waiting times and uneven access to specialists have become increasingly common. The mira platform enables opticians and trained technicians to perform key eye measurements — such as retinal imaging, intraocular pressure checks, slit‑lamp imaging, refraction data capture, and visual acuity tests — at local points of care. These results are then securely transmitted to ophthalmologists through the platform for rapid remote review and evaluation, significantly reducing diagnostics turnaround from months to 24–48 hours, and providing patients with timely reports that can guide further medical follow‑up when needed.
Mirantus Health’s approach aims to create “low‑threshold access points” for eye screening, particularly in areas where specialist shortages are most acute. Nearly 30 per cent of practicing ophthalmologists in Germany are aged 60 or older and nearing retirement, a demographic trend intensifying wait lists and increasing pressure on existing services. By enabling distributed screening and digital evaluation workflows, the company’s technology helps expand capacity without adding the same strain to traditional ophthalmology clinics.
The funding will support the company’s plans to broaden the deployment of mira and to increase the number of active screening locations from around 200 sites to more than 1,000 locations across Germany, Austria and Switzerland by 2027, enhancing early detection and preventative eye care access for a broader population. The capital will also fuel further development of the underlying software platform, including enhancements to analytics, user workflows and integration capabilities that support clinical partners and care providers.
Mirantus Health’s vision extends beyond simple screening: it seeks to streamline the patient journey from initial screening through specialist evaluation and onward referral. In cases where abnormalities are detected, mira can facilitate connections to follow‑up care through a nationwide network of more than 400 ophthalmologists, helping reduce delays and improve continuity of patient care. This integrated model has resonance in both urban and rural areas, where access to specialists can vary widely and often significantly impact health outcomes.
Dominik Pederzani has underscored that the new funding and expanded rollout represent a meaningful step toward addressing the structural challenges facing eye‑care systems across Europe. By leveraging digital tools and collaborative clinical networks, Mirantus Health’s model is designed to both relieve pressure on specialist practices and deliver timely insights to patients through a standardised, scalable process.
Investors backing the company’s growth emphasise the urgent need for technological solutions that can bridge gaps in specialist care delivery. The combination of strategic capital from institutional backers with domain expertise from health‑oriented individual investors positions Mirantus Health to capitalise on broader trends in telemedicine and distributed care, where remote support and digital workflows are increasingly seen as essential complements to traditional healthcare infrastructure.
The seed round represents a significant milestone for the startup, setting the stage for an ambitious expansion across the DACH region and potentially into other European healthcare markets. With the freshly raised capital, Mirantus Health aims to strengthen its role at the intersection of digital health, telemedicine and early detection, ultimately advancing more accessible and efficient eye care for millions of patients.
